UNSPSC 51111837: Bifluranol

This classification denotes an anti-androgen with the molecular formula C17H18F2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 47602X79JF, chemically known as phenol, 4,4-(1-ethyl-2-methyl-1,2-ethanediyl)bis(2-fluoro-, (r*,s*)- but generally known as bifluranol, which bears US NIH Compound Identifier 71713. European Medicines Agency schedules Bifluranol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05830MIG.

UNSPSC 51111837 Bifluranol is a Commodity code under which state and local governments procure generic pharmaceuticals and over-the-counter products through cooperative purchasing vehicles. The work involves supplying manufacturers' products with specific National Drug Codes (NDC), SKUs, UPCs, generic descriptions, strength, dosage forms, trade names, packaging configurations, and manufacturing locations to authorized wholesalers that distribute across government health facilities. Vendors must certify compliance with current Good Manufacturing Practices (cGMP) and the Drug Supply Chain Security Act (DSCSA), maintain contractual relationships with at least two of three authorized wholesalers with chargeback systems in place, and demonstrate pricing flexibility through multiple formats including flat price, net price (NF30, NF60, NF90), or WAC-minus structures. Issuing bodies include state multistate cooperative purchasing alliances and participating state and local government facilities; the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, is a primary repeat buyer for this category of pharmaceutical products.

The code shows recent activity in Minnesota and Oregon. MMCAP issued a Request for Proposal (S1070000015802) on January 20, 2026, with proposals due March 26, 2026, to establish multiple contracts for generic multi-source pharmaceuticals and OTC products. All products must be available in the marketplace by May 15, 2026, with contract effectiveness as of July 1, 2026. Evaluation weighting emphasizes price competitiveness (75 percent) over administrative compliance and EDI capability (5 percent each), fixed pricing (10 percent), and administrative fee agreement (5 percent). Vendors must maintain comprehensive insurance including $5,000,000 commercial general liability per occurrence, submit pricing and product information through ePro using Google Chrome in designated CSV format, and accept performance penalties ranging from $200 to $1,500 per violation. The contract term is two years for new responders with optional extensions at MMCAP's sole discretion.